Abstract
We studied the effect of combination treatment with T-activin and vitamin E on acute toxicity and antitumor activity of cyclophosphamide in mice. Combined administration of these preparations 1.37-fold increased the maximum permissible dose of cyclophosphamide without affecting its LD50 and delayed mouse death from cyclophosphamide toxicity. Most mice died only 3 days after combination treatment with the test preparations and cyclophosphamide in doses of LD16-LD84. The second peak of death from hematologic toxicity of cyclophosphamide was absent under these conditions. T-activin and vitamin E did not abolish the antitumor effect of cyclophosphamide on mice with subcutaneously implanted P-388 lympholeukemia. Tumor growth was suppressed by 100%.
Similar content being viewed by others
REFERENCES
N. D. Bunyatyan, O. A. Gerasimova, T. S. Sakharova, and L. V. Yakovleva, Eksper. Klin. Farmakol., 62, No. 2, 64–67 (1999).
M. I. Bushma, L. F. Legon'kova, I. V. Zverinskii, and A. V. Vasil'ev, Byull. Eksp. Biol. Med., 129, No. 1, 56–60 (2000).
M. L. Gershanovich, Complications of Chemotherapy of Malignant Tumors [in Russian], Moscow (1982).
V. M. Gorodetskii, Gematol. Transfuziol., No. 1, 11–15 (1998).
L. F. Dmitriev, M. V. Ivanova, and A. V. Lebedev, Byull. Eksp. Biol. Med., 120, No. 9, 268–270 (1995).
A. M. Dygai, L. A. Gur'yantseva, V. V. Zhdanov, et al., Eksper. Klin. Farmakol., No. 6, 34–36 (2000).
A. S. Kolbin, S. D. Popov, E. M. Boichenko, and E. M. Petrova, Gematol. Transfuziol., No. 6, 29–30 (1999).
K. D. Pletsityi, Immunologiya, No. 1, 72–73 (1985).
I. A. Sokirchenko and V. A. Shkurupii, Byull. Eksp. Biol. Med., 103, No. 2, 226–229 (1987).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mufazalova, N.A., Treshchalin, I.D., Treshchalina, E.M. et al. Effects of T-Activin and Vitamin E on Toxicity and Antitumor Activity of Cyclophosphamide. Bulletin of Experimental Biology and Medicine 137, 37–39 (2004). https://doi.org/10.1023/B:BEBM.0000024381.69886.45
Issue Date:
DOI: https://doi.org/10.1023/B:BEBM.0000024381.69886.45